CN106912929A - 一种具有抗疲劳功能的保健食品营养剂及制备方法 - Google Patents
一种具有抗疲劳功能的保健食品营养剂及制备方法 Download PDFInfo
- Publication number
- CN106912929A CN106912929A CN201511009433.4A CN201511009433A CN106912929A CN 106912929 A CN106912929 A CN 106912929A CN 201511009433 A CN201511009433 A CN 201511009433A CN 106912929 A CN106912929 A CN 106912929A
- Authority
- CN
- China
- Prior art keywords
- health food
- fatigue effect
- nutritional agents
- preparation
- food nutritional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 29
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 25
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 25
- 235000013402 health food Nutrition 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000011122 softwood Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 4
- 238000002242 deionisation method Methods 0.000 claims description 3
- 238000009775 high-speed stirring Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 10
- 230000002265 prevention Effects 0.000 abstract description 7
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 6
- 235000012054 meals Nutrition 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 229930003427 Vitamin E Natural products 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 5
- 201000011510 cancer Diseases 0.000 abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 5
- 235000012680 lutein Nutrition 0.000 abstract description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract description 5
- 229960005375 lutein Drugs 0.000 abstract description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract description 5
- 239000001656 lutein Substances 0.000 abstract description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract description 5
- 235000019165 vitamin E Nutrition 0.000 abstract description 5
- 229940046009 vitamin E Drugs 0.000 abstract description 5
- 239000011709 vitamin E Substances 0.000 abstract description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 230000036737 immune function Effects 0.000 abstract description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 3
- 235000005911 diet Nutrition 0.000 abstract description 3
- 229940107666 astragalus root Drugs 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 229960005436 inositol nicotinate Drugs 0.000 abstract description 2
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 230000000378 dietary effect Effects 0.000 abstract 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 235000013325 dietary fiber Nutrition 0.000 description 7
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 4
- 229960000367 inositol Drugs 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000142 dyskinetic effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种具有抗疲劳功能的保健食品营养剂及制备方法,所述具有抗疲劳功能的保健食品营养剂包括肌醇烟酸酯,膳食纤维素,维生素E粉,水溶性叶黄素,玛卡提取物,黄芪提取物,淀粉。本发明的产品具有润肠和滋补的效用,能增强人体免疫功能,提高抗病能力,延缓衰老。在膳食中添加对预防糖尿病、高脂血症、心脑血管病及癌症,并且对保护视力与抗疲劳有一定辅助作用。
Description
技术领域
本发明属于食品营养剂技术领域,具体涉及一种具有抗疲劳功能的保健食品营养剂及制备方法。
背景技术
随着我国综合实力的不断增强,人们普遍追求膳食结构的精细化,粗茶淡饭已经被明显边缘化。经过精细加工的粮食中的大量人类所必需的营养物质被加工丢失,食品的过度精细化,造成人们的健康水平普遍下降。心血管病患病率的直线上升,超过20%的人群不同程度患有糖尿病,长期便秘己成司空见惯,心脑血管病、癌症的发病率直线上升,这些都与食品过度精细化导致的人类必须的营养物质摄入量不足或缺失有直接关系。但是,人们还远远没有认识到这对身体健康影响的严重性。因此,研发生产膳食营养强化剂,添加在精细食品中,使人们在享受精细食品的同时,被动摄入所必须的营养物质。因此,在不改变人们生活***的目的,具有非常重要的现实意义。
发明内容
本发明的目的在于解决上述的技术问题而提供一种具有抗疲劳功能的保健食品营养剂及制备方法。
为实现上述目的,本发明采用如下技术方案:
一种具有抗疲劳功能的保健食品营养剂,每100g中包括以下原料组份:
余量为淀粉。
一种所述具有抗疲劳功能的保健食品营养剂的制备方法,包括以下步骤:
1)按所述质量配比称取预处理好的原料组份放入搅拌机内搅拌均匀;
2)在搅拌的同时喷入湿润剂至被搅拌的物料中形成软材;
3)将该软材经高速搅拌制粒机挤压切剖制成湿颗粒;
4)将该湿颗粒烘干,使湿颗粒含水量降到3%-8%以下;
5)将干燥的颗粒过80目筛,即制得所述具有抗疲劳功能的保健食品营养剂。
所述预处理好的原料组份是指过100目筛后原料组份。
所述湿润剂为去离子无菌水。
步骤2)中,具体为,将该湿颗粒在60℃的温度下烘干,使湿颗粒含水量降到5%以下。
肌醇烟酸酯是一种温和的周围血管扩张剂,在体内逐渐水解为烟酸和肌醇,故具有烟酸和肌醇二者的药理作用,具阵脂作用。其血管扩张作用较烟酸缓和而持久,没有服用烟酸后的潮红和胃部不适等副作用。本品可选择性的使病变部位和受寒冷剌激的敏感部位的血管扩张,而对正常血管的扩张作用则较弱。此外井有溶解血栓、抗凝、抗脂肪肝、降低毛细血管脆性等作用。肌醇烟酸醋可用于高脂血症、动脉粥样硬化、各种末梢血管障碍性疾病(如闭塞性动脉硬化症、肢端动脉痊孪症、冻伤、血管性偏头痛等)的辅助治疗。在膳食中常规添加可有效预防高脂血症、动脉粥样硬化、各种末梢血管障碍性疾病,提高免疫功能,增强抗病能力,延缓衰老。
膳食纤维可促边人体内血脂和脂蛋白的代谢,降低脂类的吸收水平,降低血脂浓度和血液粘度,保持血管通畅,防止和减缓动脉硬化和心脑血管的发病率。膳食纤维能吸附胆固醇,阻止其被人体吸收,并能促进胆酸从粪便中排出,减少胆固醇在体内的生成量,从而降低了血胆固醇的含量,对防治冠心病有一定作用。膳食纤维能影响可利用碳水化合物的吸收,使人不容易产生饥饿感,对肥胖症有很好的防治作用。膳食纤维可促进肠道蠕动,缩短肠内容物通过时间,具有通便作用,可减少致癌物被人体吸收的可能,从而减少患癌症的诱因,随着经济收入的提高和社会的富有,人们越来越追求食品的精细化,从而导致现代人摄入的膳食纤维越来越少,习惯性便秘己成为国人的通病,随之而来的是糖尿病、心脑血管病、癌症的发病率越来越多。因此,在人们追求的精细化食品中添加膳食纤维,使现代人在享受高度精细化食品的同时,被动摄入膳食纤维己是非常必要。
维生素E是参与细胞DNA和激素的合成的重要物质,能保护T淋巴细胞、保护红细胞、抗自由基氧化、抑制血小板聚集从而降低心肌梗死和脑梗塞的发病率。维生素E还能促进性激素分泌,使男子***活力和数量增加;使女子***浓度增高,提高生育能力,预防流产。维生素E具有减少皱纹产生,保持青春容貌;改善脂质代谢,预防冠心病、动脉粥样硬化;抗衰老和抗癌,预防器质性衰退疾病的发生;改善血液循环、保护组织、降低胆固醇、预防高血压;降低细胞需要氧量,维持生命力、耐力、持久力;强化肝细胞膜、保护肺泡细胞,降低肺部及呼吸***遭受感染的几率等诸多有益作用,因此,在人们的膳食中适当添加维生素E,会有效提高免疫功能,增强体质、延缓衰老、保持生命活力,对预防冠心病、动脉粥样硬化等多种疾病的发生具有重要意义。
叶黄素是一种性能优异的抗氧化剂,可抵御氧自由基在人体内造成细胞与器官损伤,预防机体衰老引发的心血管硬化、冠心病等症状。最重要的是叶黄素是唯一可以存在眼睛水晶体的类胡萝卜素成分,是视网膜黄斑的主要色素和抗氧化成分,许多眼科疾病都与叶黄素的缺乏有很大关系,可见叶黄素对于眼睛起着重要保护作用。在食品中加入一定量的叶黄素可预防细胞衰老和机体器官衰老,同时还可预防老年性眼球视网膜黄斑退化引起的视力下降与失明,通过一系列的医学研究,类胡萝卜素已被建议用作癌症预防剂,生命延长剂,溃疡抵制剂,心脏病发作与冠状动脉疾病的抵制剂。同时,叶黄素还可作为饲料添加剂用于家禽肉蛋的着色,同时也已在食品工业中用作着色与营养保健剂。
玛卡提取物含有4种生物碱、芥子油苷、多种维生素如蛋白质、氨基酸、多糖、矿物质和多种天然植物活性成分。这些成分已被证实与玛卡抗疲劳、抗抑郁、提高生育能力、调节内分泌有关。
黄芪提取物具有抗菌、抗病毒、抗肿瘤作用,具有一定的保健功能。
本发明的产品具有润肠和滋补的效用,能增强人体免疫功能,提高抗病能力,延缓衰老;在膳食中添加对预防糖尿病、高脂血症、心脑血管病及癌症有一定辅助作用。
具体实施方式
下面,结合实例对本发明的实质性特点和优势作进一步的说明,但本发明并不局限于所列的实施例。
实施例1
一种具有抗疲劳功能的保健食品营养剂,每100g中包括以下原料组份:
余量为淀粉。
上述具有抗疲劳功能的保健食品营养剂的制备方法,包括以下步骤:
1)按所述质量配比称取预处理好的原料组份放入搅拌机内搅拌均匀;
2)在搅拌的同时喷入湿润剂至被搅拌的物料中形成软材;
3)将该软材经高速搅拌制粒机挤压切剖制成湿颗粒;
4)将该湿颗粒烘干,使湿颗粒含水量降到3%-8%以下;
5)将干燥的颗粒过80目筛,即制得所述具有抗疲劳功能的保健食品营养剂。
所述预处理好的原料组份是指过100目筛后原料组份。
所述湿润剂为去离子无菌水。
步骤2)中,具体为,将该湿颗粒在60℃的温度下烘干,使湿颗粒含水量降到5%以下。
实施例2
一种具有抗疲劳功能的保健食品营养剂,每100g中包括以下原料组份:
余量为淀粉。
制备方法同实施例1。
实施例3
一种具有抗疲劳功能的保健食品营养剂,每100g中包括以下原料组份:
余量为淀粉。
制备方法同实施例1。
按照以上所述制备方法制成的具有抗疲劳功能的保健食品营养剂,在面粉中添加的剂量为150-200mg/kg。
本发明的具有抗疲劳功能的保健食品营养剂的毒性试验:
采取最大给药剂量给小鼠灌胃的方法对本发明的毒性进行试验。
试验采用体重为18-20克的雌雄各半的小鼠作为试验对象,随机分为对照组、试验组,小鼠以同样方式喂养。给药组按照小鼠体重计算,每10g体重灌胃本发明的具有抗疲劳功能的保健食品营养剂150mg。
小鼠灌胃后连续观察7天,小鼠的精神饱满,食欲正常,毛色、体重没有变化,没有发生死亡现象,与对照组相比未发现任何异常。证实本发明的肌醇烟酸醋具有抗疲劳功能的保健食品营养剂无明显毒性反应。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (5)
1.一种具有抗疲劳功能的保健食品营养剂,其特征在于,每100g中包括以下原料组份:
余量为淀粉。
2.根据权利要求1所述具有抗疲劳功能的保健食品营养剂的制备方法,其特征在于,包括以下步骤:
1)按所述质量配比称取预处理好的原料组份放入搅拌机内搅拌均匀;
2)在搅拌的同时喷入湿润剂至被搅拌的物料中形成软材;
3)将该软材经高速搅拌制粒机挤压切剖制成湿颗粒;
4)将该湿颗粒烘干,使湿颗粒含水量降到3%-8%以下;
5)将干燥的颗粒过80目筛,即制得所述具有抗疲劳功能的保健食品营养剂。
3.根据权利要求2所述具有抗疲劳功能的保健食品营养剂的制备方法,其特征在于,所述预处理好的原料组份是指过100目筛后原料组份。
4.根据权利要求2所述具有抗疲劳功能的保健食品营养剂的制备方法,其特征在于,所述湿润剂为去离子无菌水。
5.根据权利要求2所述具有抗疲劳功能的保健食品营养剂的制备方法,其特征在于,步骤2)中,具体为,将该湿颗粒在60℃的温度下烘干,使湿颗粒含水量降到5%以下。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511009433.4A CN106912929A (zh) | 2015-12-25 | 2015-12-25 | 一种具有抗疲劳功能的保健食品营养剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511009433.4A CN106912929A (zh) | 2015-12-25 | 2015-12-25 | 一种具有抗疲劳功能的保健食品营养剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106912929A true CN106912929A (zh) | 2017-07-04 |
Family
ID=59455440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511009433.4A Pending CN106912929A (zh) | 2015-12-25 | 2015-12-25 | 一种具有抗疲劳功能的保健食品营养剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106912929A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927739A (zh) * | 2017-12-26 | 2018-04-20 | 北京牧笛生物科技有限公司 | 一种食品营养强化剂及其制备方法 |
-
2015
- 2015-12-25 CN CN201511009433.4A patent/CN106912929A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927739A (zh) * | 2017-12-26 | 2018-04-20 | 北京牧笛生物科技有限公司 | 一种食品营养强化剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108112996A (zh) | 一种控制2型糖尿病人群高血糖和提高免疫力的营养组合物 | |
CN102406860A (zh) | 预防和治疗糖尿病的组合物、其制备方法及应用 | |
JP2018510641A (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
CN102090637A (zh) | 一种含有胶原蛋白的复方营养粉 | |
CN106912929A (zh) | 一种具有抗疲劳功能的保健食品营养剂及制备方法 | |
CN107998271A (zh) | 一种***性降低血糖修复受损细胞的中药和保健品 | |
CN107136490A (zh) | 一种肽虫草保健品 | |
CN106912917A (zh) | 一种肌醇烟酸酯食品营养剂及制备方法 | |
CN106912955A (zh) | 一种食品营养保健添加剂及制备方法 | |
CN106912912A (zh) | 一种具有抗胃肿瘤功能的食品营养强化剂及制备方法 | |
CN106912911A (zh) | 一种保健食品营养强化剂及制备方法 | |
CN106912910A (zh) | 一种食品营养强化剂及制备方法 | |
CN106912932A (zh) | 一种抗肿瘤食品营养强化剂及制备方法 | |
CN106912956A (zh) | 一种食品营养剂及制备方法 | |
CN106912944A (zh) | 一种含肌醇烟酸酯及玛卡蓝莓的食品营养剂及制备方法 | |
CN106912915A (zh) | 一种食品营养保健强化剂及制备方法 | |
CN106912931A (zh) | 一种具有抗肿瘤功能的食品营养强化剂及制备方法 | |
CN106912930A (zh) | 一种安全性食品营养保健强化剂及制备方法 | |
CN106912916A (zh) | 一种具有保健功能的肌醇烟酸酯食品营养剂及制备方法 | |
CN106912919A (zh) | 一种具有保健功能的食品营养剂及制备方法 | |
CN106912938A (zh) | 一种肌醇烟酸酯螺旋藻食品营养剂及制备方法 | |
CN107927739A (zh) | 一种食品营养强化剂及其制备方法 | |
CN106912937A (zh) | 一种肌醇烟酸酯螺旋藻食品营养强化剂及制备方法 | |
CN106912934A (zh) | 一种食品级保健营养强化剂及制备方法 | |
CN107510708A (zh) | 一种马齿苋蒲公英袪疹膏及用法食品药膏日化品理疗膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170704 |
|
WD01 | Invention patent application deemed withdrawn after publication |